Cardiovascular disease: BET inhibitor attenuates heart failure
Nature Reviews Drug Discovery 16, 453 (2017).
doi:10.1038/nrd.2017.125
Author: Megan Cully
Heart failure (HF) is a leading cause of mortality and hospitalization. Writing in Science Translational Medicine, Duan and colleagues demonstrate that inhibition of bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extraterminal domain (BET) family of epigenetic signalling proteins, reduces pathology and
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Megan Cully Tags: Research Highlight Source Type: research
More News: Cardiology | Cardiovascular | Drugs & Pharmacology | Heart | Heart Failure | Pathology | Science